Presentation is loading. Please wait.

Presentation is loading. Please wait.

Tashkent Medical Academy

Similar presentations


Presentation on theme: "Tashkent Medical Academy"— Presentation transcript:

1 Tashkent Medical Academy
Peptic Ulcer Disease

2

3 Erect radiographic image of esophagus (lower portion), stomach and first part of duodenum after ingestion of contrast medium

4 Topography and internal surface of a stomach
(blue line represent notional lines marking the parts of the stomach)

5 Microscopic section of a gastric gland

6 Cells THE PARIETAL CELLS – acid secretion
THE CHIEF CELLS – pepsinogen secretion THE ENDOCRINE CELLS: The G-cells – gastrin secretion The D-cells – somatostatin secretion The ECL-cells – histamine production THE MUCOUS NECK CELLS – mucus secretion

7 Components involved in providing gastroduodenal mucosal defense and repair

8 Peptic ulcer disease Primary chronic recurrent disease of upper gastrointestinal tract associated with circumscribed ulcers within stomach and duodenum

9 Ulcer is disruption of the mucosal integrity of the stomach and/or duodenum leading to a local defect or excavation due to active inflammation

10 1 – submucosa 2 – hard, undermined margin

11 Peptic Ulcers: Gastric & Dudodenal

12 Erosion A break in the mucosa not penetrating muscularis mucosa
Peristalsis is not affected Heals rapidly

13 Epidemiology Duodenal ulcers (5x) > gastric ulcers ♂ (4x) > ♀
Urban resident > rural resident

14 Etiology Helicobacter pylori NSAIDs (aspirin)

15 H.pylori in GI diseases Healthy subjects 20-50%
Chronic active gastritis % Duodenal ulcer >90% Gastric ulcer % Gastric adenocarcinoma 90% Gastric lymphoma %

16 Barry Marshal Robin Warran

17 Factors Predisposing factors Heredity Emotional stress Blood group
Producing factors Active duodenitis or gastritis Gastric metaplasia

18 Aggravating causes of, and defense mechanisms against, peptic ulceration

19 Locations of ulcers Any area where pepsin and acid are present
Prevailing locations Duodenum: duodenal bulb Stomach: over lesser curvature

20 Johnson’s classification (according to site, clinical manifestations)
I type – ulcers of lesser curvature of stomach II type – combined ulcers of stomach and duodenum III type – ulcers of prepyloric part stomach IV type – ulcers of duodenum

21 Forms (according to severity)
Mild 1 time/year Exacerbations Easily treated Few symptoms Medium-severe 2-3 times/year Treated by full course therapy Severe Frequent exacerbations Absence of stable remission Evident clinical manifestation

22 PAIN Clinical features LOCATION
Gastric ulcer: in the centre of or left to epigastrium Duodenal ulcer: to the right of midline in epigastruim TIME Early: h after meal, duration hh, in gastric ulcers Late: hh after meal, in duodenal and pyloric ulcers Nocturnal Pain of “hunger”: 6-7 hh after meal and ceased after meal CHARACTER Burning Gnawing Dull Cramplike IRRADIATION Cardiac area Left scapula Thoracic part of spinal column Lumbar region PAIN RELIEF Antacids Milk Meal After vomiting

23 DYSPEPSIA Clinical features HEARTBURN
Related with gastroesophageal reflux After meal BELCHING More common in gastric ulcers NAUSEA & VOMITING At the peak of pain Pain relief after vomiting APPETITE Excessive

24 Clinical examination Vegetative dystonia: cold, damp palms, mottled skin, bradycardia, hypotension Palpation: tenderness Percussion: Mendel’s symptom, succussion splash (gastric outlet obstruction)

25 GP in Uzbekistan Non-complicated PUD – service of 1st category
Complicated PUD – service of 2nd category Services of 3.1 category: Professional examination Interpretation of clinical and biochemical tests CBC Gastric lavage Diet prescription Services of 3.2 category: Analysis of gastric juice and duodenal contents Ultrasound Endoscopy Radiologic examination Biopsy Services of 4 category: Rational nutrition Struggle with harmful habits Personal hygiene

26 Laboratory and instrumental examination
CBC ↑Hb ↑Erythrocyte Secretory function of stomach ↑BAO (N=5 mmol/h) ↑MAO (N=18-26 mmol/h) Occult blood feces analysis Latent PUD Exacerbation Stomach cancer Endoscopy Round or oval Edges: sharp, hyperemic, edematous (Barium meal) X-ray Niche sign Retention of barium meal Duodenogastric reflux Fold convergence Local spasm of stomach *BAO – basal acid output *MAO – maximal acid output Biopsy Test with Insulin Test with Histamine pH meter Gastrin concentration in serum

27 Diagnosis of Helicobacter pylori infection
Invasive( through endoscopy) Gastric biopsy and staining Culture of biopsy specimen Tests using urease enzyme in biopsy specimens Non-invasive: Urea breath test H.pylori antibodies Stool antigen Salivary antigen

28 Radiology in PUD

29 Duodenal Ulcer

30 Peptic Ulcers: Gastric & Dudodenal

31 Gastric ulcer in endoscopy

32 Gastric ulcer

33 Gastric erosions

34 Duodenal ulcer

35 Duodenal ulcer

36 20% Complications Haemorrhage Perforation
Penetration (pancreas, liver) Pyloric stenosis (due to scarring) Malignization 20%

37 Haemorrhage

38 Haemorrhage Hematemesis Melena Bergman’s symptom

39 Stages of bleeding by Forrest (endoscopy)
I STAGE Actively bleeding ulcer II STAGE Signs of stopped fresh haemorrhage Thrombosed vessels at the bottom of ulcer Clot of blood III STAGE Absence of bleeding apparent signs

40 Ulcer perforation

41 Gastric outlet stenosis

42 Stages of stenosis Compensation 1-0.5 cm Subcompensation 0.5-0.3 cm
Decompensation <0.3 cm

43 Differential Diagnosis
Neoplasm of the stomach Pancreatitis Pancreatic cancer Diverticulitis Nonulcer dyspepsia (also called functional dyspepsia) Cholecystitis Gastritis MI—not to be missed if having chest pain

44 Treatment – Medical nutrition
Diet №1: white stale bread, vegetable soups, softly boiled porridge, potato mash, fish, birds, mature fruits, berry and fruit juices, cottage cheese, milk, omelette, pudding Banned: spicy foods, marinated and smoked products Frequent small meals: 6-7 times a day

45 Treatment - Drugs H.pylori supressors: De-nol, Metronidazole, Furazolidone, Oxacillin, Amoxycillin Antisecretory drugs M-anticholinergic drugs: Nonselective: Atropine, Platyphyllin, Methacin Selective: Gastrozepine, Pirenzepine H2-histamine receptor blockers: Cimetidine, Ranitidine, Famotidine Proton pomp inhibitors: Omeprazole, Lansoprazole, Rabeprazole Antagonists of gastrin receptors: Milid, Proglumide Antacids: Magnesium hydroxide, Aluminum hydroxide, Almagel, Maalox

46 Treatment - Drugs Gastrocytoprotectors
Cytoprotectors that stimulate mucus production: Carbenoxolone, synthetic prostaglandins (Enprostile, Misoprostole) Cytoprotectors that form protective film: Sucralfate, colloid bismuth (De-nol), Smecta Astringents: Vicaline, Vicair Drugs that normalize motor function of stomach and duodenum (Metoclopramide), spasmolytics (Papaverine, No-spa)

47 Side effects of drugs H2-blockers: gynecomastia, impotence
Aluminum hydroxide: constipation Magnesium hydroxide: diarrhea

48 Therapy regimens MONOTHERAPY
De-nol 1 tablet 3 times/day, 4-6 weeks Clarythromycin 250 mg, 2 times/day, 7-10 days Metronidazole 250 mg, 4 times/day, 14 days

49 Therapy regimens DOUBLE THERAPY
De-nol [4-6 weeks] + Metronidazole [10-14 days] De-nol [4-6 weeks] + Tetracyclin OR Amoxycillin [10 days] Amoxycillin OR Clarythromycin [7- 10 days] + Omeprazole [40 mg, 4-6 weeks]

50 Therapy regimens TRIPLE THERAPY
De-nol [4-6 weeks] + Metronidazole [10-14 days] Tetracyclin [7-10 days] Omeprazole + Amoxycillin OR Clarythromycin + Metronidazole Metronidazole [10-14 days] + Amoxycillin [10 days] + Ranitidine [150 mg, days] A week

51 Therapy regimens QUADRUPLE THERAPY
Omeprazole + De-nol+ Amoxycillin OR Clarythromycin + Metronidazole 10 days

52 Prophylaxy Primary Revelation and elimination of risk factors
Sanitary and prophylactic measures Secondary Early diagnosis and timely treatment Screening, professional examination, questionnarires Tertiary Prevention of complications

53 To avoid sickness, eat less; to prolong life, worry less. Chu Hui Weng

54 THANKS FOR YOUR ATTENTION AND PATIENCE!!!


Download ppt "Tashkent Medical Academy"

Similar presentations


Ads by Google